Rites (RITES)

FairStock Score: 57/100 — STEADY

Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 1/2 · Dividend: 1/1

Key Financials

Strengths

• Zero debt (D/E=0.00) and high ROCE of 21.82% show disciplined capital allocation without leverage.
• Piotroski F-Score of 8/9 and free cash flow of ₹432 Cr confirm strong earnings quality and cash generation.
• ROE of 15.64% with promoter holding of 72.20% aligns governance and rewards patient shareholders.
• Dividend yield of 3.53% provides a real income cushion in an otherwise muted-growth story.

Concerns

• Top-line stagnation: sales growth is only 0.75%; profit growth of 9.21% relies on margin or other income rather than core expansion.
• Valuation is rich: P/E of 24.89 and P/B of 4.03 stand far above the Graham Number of ₹103.04 and DCF value of ₹95.37, leaving a negative margin of safety.
• Altman Z-Score of 2.11 points to a grey-zone financial profile that needs monitoring despite zero debt.
• Negative EV/EBITDA of -511.61 is an anomaly that demands balance-sheet scrutiny before relying on market-based multiples.

AI Analysis

At first glance, Rites has traits I admire: zero debt, a return on capital of 21.82%, and a steady 15.64% ROE that suggests existing capital is put to work without leverage. The Piotroski score of 8/9 and ₹432 Cr of free cash flow tell me the reported profits are not paper figures. With a 72.20% promoter holding and a 3.53% dividend yield, minority shareholders are being treated as partners, not afterthoughts. But the value discipline is essential. This is a slow grower, not a compounder with momentum. Sales growth is barely 0.75%, while profit grew 9.21%—that is margin or other income doing the work, not expanding intrinsic value from the top line. At ₹221.55, the market capitalises the company at ₹10,281 Cr, or 24.89 times earnings and 4.03 times book value. The Graham number of ₹103.04 and the DCF value of ₹95.37 both sit far below the current price. My margin of safety is negative. I cannot pay more than twice a conservative estimate of value and still sleep at night, no matter how solid the balance sheet. The Altman Z-score of 2.11 is in the grey zone, and the negative EV/EBITDA of -511.61 makes me want to open the accounts before trusting any earnings multiple. But the zero-debt, high-cash-generation DNA of this company is real. If it were trading near book value or with a double-digit free cash flow yield, I would be excited. At today's price, I must be patient. Good company, but the price is not a bargain.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer